The collapsin response mediator protein (CRMP) family of intracellular phosphoproteins are predominantly expressed in the nervous system during development. These proteins play important roles in axon formation from neurites, and in neuron guidance, growth, and polarity. CRMP-2 is encoded by the DPYSL2 gene in humans. It is also known as dihydropyrimidinase-like 2 (DRP2), dihydropyrimidinase-related protein 2 (DHPRP2), unc-33-like phosphoprotein 2 (ULIP2), and N2A3. CRMP-2 promotes microtubule assembly and is required for growth cone collapse. It also plays a role in synaptic signaling through interactions with calcium channels. Mutations in the DPYSL2 gene have been implicated in multiple neurological disorders. A hyperphosphorylated form of CRMP-2 may play a key role in the development of Alzheimer's disease.
These products are affinity-purified IgG antibodies that recognize human CRMP-2 protein. The antibodies were raised in mouse using recombinant proteins or brain tissue homogenates, and can be used for Western blot (WB) detection, immunohistochemical (IHC) detection, or immunoprecipitation (IP) of human CRMP-2 protein.